Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Bio-pharma market report explains the definition, types, applications, major countries, and major players of the Bio-pharma market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Merck & Co Inc
Novartis AG GlaxoSmithKline Plc
Eli Lilly and Company
Johnson & Johnson Services
Abbott Laboratories
Sanofi, Amgen
Biogen Idec
Bristol-Myers Squibb Company
Pfizer
F Hoffmann-La Roche AG
AstraZeneca PLC
AbbVie
Bayer AG
By Type:
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
Others
By End-User:
Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Bio-pharma Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Bio-pharma Outlook to 2028- Original Forecasts
-
2.2 Bio-pharma Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Bio-pharma Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Bio-pharma Market- Recent Developments
-
6.1 Bio-pharma Market News and Developments
-
6.2 Bio-pharma Market Deals Landscape
7 Bio-pharma Raw Materials and Cost Structure Analysis
-
7.1 Bio-pharma Key Raw Materials
-
7.2 Bio-pharma Price Trend of Key Raw Materials
-
7.3 Bio-pharma Key Suppliers of Raw Materials
-
7.4 Bio-pharma Market Concentration Rate of Raw Materials
-
7.5 Bio-pharma Cost Structure Analysis
-
7.5.1 Bio-pharma Raw Materials Analysis
-
7.5.2 Bio-pharma Labor Cost Analysis
-
7.5.3 Bio-pharma Manufacturing Expenses Analysis
8 Global Bio-pharma Import and Export Analysis (Top 10 Countries)
-
8.1 Global Bio-pharma Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Bio-pharma Export by Region (Top 10 Countries) (2017-2028)
9 Global Bio-pharma Market Outlook by Types and Applications to 2022
-
9.1 Global Bio-pharma Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Recombinant Proteins Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Interferons Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Recombinant Human Insulin Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Erythropoietin Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Vaccines Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Growth Hormones Consumption and Growth Rate (2017-2022)
-
9.1.9 Global Purified Proteins Consumption and Growth Rate (2017-2022)
-
9.1.10 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Bio-pharma Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Metabolic Disorders Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Neurological Disorders Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Inflammatory and Infectious Diseases Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Bio-pharma Market Analysis and Outlook till 2022
-
10.1 Global Bio-pharma Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Bio-pharma Consumption (2017-2022)
-
10.2.2 Canada Bio-pharma Consumption (2017-2022)
-
10.2.3 Mexico Bio-pharma Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Bio-pharma Consumption (2017-2022)
-
10.3.2 UK Bio-pharma Consumption (2017-2022)
-
10.3.3 Spain Bio-pharma Consumption (2017-2022)
-
10.3.4 Belgium Bio-pharma Consumption (2017-2022)
-
10.3.5 France Bio-pharma Consumption (2017-2022)
-
10.3.6 Italy Bio-pharma Consumption (2017-2022)
-
10.3.7 Denmark Bio-pharma Consumption (2017-2022)
-
10.3.8 Finland Bio-pharma Consumption (2017-2022)
-
10.3.9 Norway Bio-pharma Consumption (2017-2022)
-
10.3.10 Sweden Bio-pharma Consumption (2017-2022)
-
10.3.11 Poland Bio-pharma Consumption (2017-2022)
-
10.3.12 Russia Bio-pharma Consumption (2017-2022)
-
10.3.13 Turkey Bio-pharma Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Bio-pharma Consumption (2017-2022)
-
10.4.2 Japan Bio-pharma Consumption (2017-2022)
-
10.4.3 India Bio-pharma Consumption (2017-2022)
-
10.4.4 South Korea Bio-pharma Consumption (2017-2022)
-
10.4.5 Pakistan Bio-pharma Consumption (2017-2022)
-
10.4.6 Bangladesh Bio-pharma Consumption (2017-2022)
-
10.4.7 Indonesia Bio-pharma Consumption (2017-2022)
-
10.4.8 Thailand Bio-pharma Consumption (2017-2022)
-
10.4.9 Singapore Bio-pharma Consumption (2017-2022)
-
10.4.10 Malaysia Bio-pharma Consumption (2017-2022)
-
10.4.11 Philippines Bio-pharma Consumption (2017-2022)
-
10.4.12 Vietnam Bio-pharma Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Bio-pharma Consumption (2017-2022)
-
10.5.2 Colombia Bio-pharma Consumption (2017-2022)
-
10.5.3 Chile Bio-pharma Consumption (2017-2022)
-
10.5.4 Argentina Bio-pharma Consumption (2017-2022)
-
10.5.5 Venezuela Bio-pharma Consumption (2017-2022)
-
10.5.6 Peru Bio-pharma Consumption (2017-2022)
-
10.5.7 Puerto Rico Bio-pharma Consumption (2017-2022)
-
10.5.8 Ecuador Bio-pharma Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Bio-pharma Consumption (2017-2022)
-
10.6.2 Kuwait Bio-pharma Consumption (2017-2022)
-
10.6.3 Oman Bio-pharma Consumption (2017-2022)
-
10.6.4 Qatar Bio-pharma Consumption (2017-2022)
-
10.6.5 Saudi Arabia Bio-pharma Consumption (2017-2022)
-
10.6.6 United Arab Emirates Bio-pharma Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Bio-pharma Consumption (2017-2022)
-
10.7.2 South Africa Bio-pharma Consumption (2017-2022)
-
10.7.3 Egypt Bio-pharma Consumption (2017-2022)
-
10.7.4 Algeria Bio-pharma Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Bio-pharma Consumption (2017-2022)
-
10.8.2 New Zealand Bio-pharma Consumption (2017-2022)
11 Global Bio-pharma Competitive Analysis
-
11.1 Merck & Co Inc
-
11.1.1 Merck & Co Inc Company Details
-
11.1.2 Merck & Co Inc Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Merck & Co Inc Bio-pharma Main Business and Markets Served
-
11.1.4 Merck & Co Inc Bio-pharma Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Novartis AG GlaxoSmithKline Plc
-
11.2.1 Novartis AG GlaxoSmithKline Plc Company Details
-
11.2.2 Novartis AG GlaxoSmithKline Plc Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Main Business and Markets Served
-
11.2.4 Novartis AG GlaxoSmithKline Plc Bio-pharma Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Eli Lilly and Company
-
11.3.1 Eli Lilly and Company Company Details
-
11.3.2 Eli Lilly and Company Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Eli Lilly and Company Bio-pharma Main Business and Markets Served
-
11.3.4 Eli Lilly and Company Bio-pharma Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Johnson & Johnson Services
-
11.4.1 Johnson & Johnson Services Company Details
-
11.4.2 Johnson & Johnson Services Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Johnson & Johnson Services Bio-pharma Main Business and Markets Served
-
11.4.4 Johnson & Johnson Services Bio-pharma Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Abbott Laboratories
-
11.5.1 Abbott Laboratories Company Details
-
11.5.2 Abbott Laboratories Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Abbott Laboratories Bio-pharma Main Business and Markets Served
-
11.5.4 Abbott Laboratories Bio-pharma Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Sanofi, Amgen
-
11.6.1 Sanofi, Amgen Company Details
-
11.6.2 Sanofi, Amgen Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Sanofi, Amgen Bio-pharma Main Business and Markets Served
-
11.6.4 Sanofi, Amgen Bio-pharma Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Biogen Idec
-
11.7.1 Biogen Idec Company Details
-
11.7.2 Biogen Idec Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Biogen Idec Bio-pharma Main Business and Markets Served
-
11.7.4 Biogen Idec Bio-pharma Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Bristol-Myers Squibb Company
-
11.8.1 Bristol-Myers Squibb Company Company Details
-
11.8.2 Bristol-Myers Squibb Company Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Bristol-Myers Squibb Company Bio-pharma Main Business and Markets Served
-
11.8.4 Bristol-Myers Squibb Company Bio-pharma Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Pfizer
-
11.9.1 Pfizer Company Details
-
11.9.2 Pfizer Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Pfizer Bio-pharma Main Business and Markets Served
-
11.9.4 Pfizer Bio-pharma Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 F Hoffmann-La Roche AG
-
11.10.1 F Hoffmann-La Roche AG Company Details
-
11.10.2 F Hoffmann-La Roche AG Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 F Hoffmann-La Roche AG Bio-pharma Main Business and Markets Served
-
11.10.4 F Hoffmann-La Roche AG Bio-pharma Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 AstraZeneca PLC
-
11.11.1 AstraZeneca PLC Company Details
-
11.11.2 AstraZeneca PLC Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 AstraZeneca PLC Bio-pharma Main Business and Markets Served
-
11.11.4 AstraZeneca PLC Bio-pharma Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 AbbVie
-
11.12.1 AbbVie Company Details
-
11.12.2 AbbVie Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 AbbVie Bio-pharma Main Business and Markets Served
-
11.12.4 AbbVie Bio-pharma Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Bayer AG
-
11.13.1 Bayer AG Company Details
-
11.13.2 Bayer AG Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Bayer AG Bio-pharma Main Business and Markets Served
-
11.13.4 Bayer AG Bio-pharma Product Portfolio
-
11.13.5 Recent Research and Development Strategies
12 Global Bio-pharma Market Outlook by Types and Applications to 2028
-
12.1 Global Bio-pharma Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Recombinant Proteins Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Interferons Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Recombinant Human Insulin Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Erythropoietin Consumption Forecast and Growth Rate (2022-2028)
-
12.1.7 Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
12.1.8 Global Growth Hormones Consumption Forecast and Growth Rate (2022-2028)
-
12.1.9 Global Purified Proteins Consumption Forecast and Growth Rate (2022-2028)
-
12.1.10 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Bio-pharma Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Inflammatory and Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Bio-pharma Market Analysis and Outlook to 2028
-
13.1 Global Bio-pharma Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Bio-pharma Consumption Forecast (2022-2028)
-
13.2.2 Canada Bio-pharma Consumption Forecast (2022-2028)
-
13.2.3 Mexico Bio-pharma Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Bio-pharma Consumption Forecast (2022-2028)
-
13.3.2 UK Bio-pharma Consumption Forecast (2022-2028)
-
13.3.3 Spain Bio-pharma Consumption Forecast (2022-2028)
-
13.3.4 Belgium Bio-pharma Consumption Forecast (2022-2028)
-
13.3.5 France Bio-pharma Consumption Forecast (2022-2028)
-
13.3.6 Italy Bio-pharma Consumption Forecast (2022-2028)
-
13.3.7 Denmark Bio-pharma Consumption Forecast (2022-2028)
-
13.3.8 Finland Bio-pharma Consumption Forecast (2022-2028)
-
13.3.9 Norway Bio-pharma Consumption Forecast (2022-2028)
-
13.3.10 Sweden Bio-pharma Consumption Forecast (2022-2028)
-
13.3.11 Poland Bio-pharma Consumption Forecast (2022-2028)
-
13.3.12 Russia Bio-pharma Consumption Forecast (2022-2028)
-
13.3.13 Turkey Bio-pharma Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Bio-pharma Consumption Forecast (2022-2028)
-
13.4.2 Japan Bio-pharma Consumption Forecast (2022-2028)
-
13.4.3 India Bio-pharma Consumption Forecast (2022-2028)
-
13.4.4 South Korea Bio-pharma Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Bio-pharma Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Bio-pharma Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Bio-pharma Consumption Forecast (2022-2028)
-
13.4.8 Thailand Bio-pharma Consumption Forecast (2022-2028)
-
13.4.9 Singapore Bio-pharma Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Bio-pharma Consumption Forecast (2022-2028)
-
13.4.11 Philippines Bio-pharma Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Bio-pharma Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Bio-pharma Consumption Forecast (2022-2028)
-
13.5.2 Colombia Bio-pharma Consumption Forecast (2022-2028)
-
13.5.3 Chile Bio-pharma Consumption Forecast (2022-2028)
-
13.5.4 Argentina Bio-pharma Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Bio-pharma Consumption Forecast (2022-2028)
-
13.5.6 Peru Bio-pharma Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Bio-pharma Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Bio-pharma Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Bio-pharma Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Bio-pharma Consumption Forecast (2022-2028)
-
13.6.3 Oman Bio-pharma Consumption Forecast (2022-2028)
-
13.6.4 Qatar Bio-pharma Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Bio-pharma Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Bio-pharma Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Bio-pharma Consumption Forecast (2022-2028)
-
13.7.2 South Africa Bio-pharma Consumption Forecast (2022-2028)
-
13.7.3 Egypt Bio-pharma Consumption Forecast (2022-2028)
-
13.7.4 Algeria Bio-pharma Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Bio-pharma Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Bio-pharma Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Bio-pharma
-
Figure of Bio-pharma Picture
-
Table Global Bio-pharma Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Bio-pharma Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant Proteins Consumption and Growth Rate (2017-2022)
-
Figure Global Granulocyte-Colony Stimulating Factor (G-CSF) Consumption and Growth Rate (2017-2022)
-
Figure Global Interferons Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant Human Insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Erythropoietin Consumption and Growth Rate (2017-2022)
-
Figure Global Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Growth Hormones Consumption and Growth Rate (2017-2022)
-
Figure Global Purified Proteins Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Metabolic Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Neurological Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Inflammatory and Infectious Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Bio-pharma Consumption by Country (2017-2022)
-
Table North America Bio-pharma Consumption by Country (2017-2022)
-
Figure United States Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Canada Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Mexico Bio-pharma Consumption and Growth Rate (2017-2022)
-
Table Europe Bio-pharma Consumption by Country (2017-2022)
-
Figure Germany Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure UK Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Spain Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Belgium Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure France Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Italy Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Denmark Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Finland Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Norway Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Sweden Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Poland Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Russia Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Turkey Bio-pharma Consumption and Growth Rate (2017-2022)
-
Table APAC Bio-pharma Consumption by Country (2017-2022)
-
Figure China Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Japan Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure India Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure South Korea Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Thailand Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Singapore Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Philippines Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Bio-pharma Consumption and Growth Rate (2017-2022)
-
Table South America Bio-pharma Consumption by Country (2017-2022)
-
Figure Brazil Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Colombia Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Chile Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Argentina Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Peru Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Bio-pharma Consumption and Growth Rate (2017-2022)
-
Table GCC Bio-pharma Consumption by Country (2017-2022)
-
Figure Bahrain Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Oman Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Qatar Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Bio-pharma Consumption and Growth Rate (2017-2022)
-
Table Africa Bio-pharma Consumption by Country (2017-2022)
-
Figure Nigeria Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure South Africa Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Egypt Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Algeria Bio-pharma Consumption and Growth Rate (2017-2022)
-
Table Oceania Bio-pharma Consumption by Country (2017-2022)
-
Figure Australia Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Bio-pharma Consumption and Growth Rate (2017-2022)
-
Table Merck & Co Inc Company Details
-
Table Merck & Co Inc Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Inc Bio-pharma Main Business and Markets Served
-
Table Merck & Co Inc Bio-pharma Product Portfolio
-
Table Novartis AG GlaxoSmithKline Plc Company Details
-
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Main Business and Markets Served
-
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Product Portfolio
-
Table Eli Lilly and Company Company Details
-
Table Eli Lilly and Company Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Bio-pharma Main Business and Markets Served
-
Table Eli Lilly and Company Bio-pharma Product Portfolio
-
Table Johnson & Johnson Services Company Details
-
Table Johnson & Johnson Services Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Services Bio-pharma Main Business and Markets Served
-
Table Johnson & Johnson Services Bio-pharma Product Portfolio
-
Table Abbott Laboratories Company Details
-
Table Abbott Laboratories Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Bio-pharma Main Business and Markets Served
-
Table Abbott Laboratories Bio-pharma Product Portfolio
-
Table Sanofi, Amgen Company Details
-
Table Sanofi, Amgen Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi, Amgen Bio-pharma Main Business and Markets Served
-
Table Sanofi, Amgen Bio-pharma Product Portfolio
-
Table Biogen Idec Company Details
-
Table Biogen Idec Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Idec Bio-pharma Main Business and Markets Served
-
Table Biogen Idec Bio-pharma Product Portfolio
-
Table Bristol-Myers Squibb Company Company Details
-
Table Bristol-Myers Squibb Company Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Bio-pharma Main Business and Markets Served
-
Table Bristol-Myers Squibb Company Bio-pharma Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Bio-pharma Main Business and Markets Served
-
Table Pfizer Bio-pharma Product Portfolio
-
Table F Hoffmann-La Roche AG Company Details
-
Table F Hoffmann-La Roche AG Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche AG Bio-pharma Main Business and Markets Served
-
Table F Hoffmann-La Roche AG Bio-pharma Product Portfolio
-
Table AstraZeneca PLC Company Details
-
Table AstraZeneca PLC Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca PLC Bio-pharma Main Business and Markets Served
-
Table AstraZeneca PLC Bio-pharma Product Portfolio
-
Table AbbVie Company Details
-
Table AbbVie Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Bio-pharma Main Business and Markets Served
-
Table AbbVie Bio-pharma Product Portfolio
-
Table Bayer AG Company Details
-
Table Bayer AG Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Bio-pharma Main Business and Markets Served
-
Table Bayer AG Bio-pharma Product Portfolio
-
Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Recombinant Proteins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Granulocyte-Colony Stimulating Factor (G-CSF) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interferons Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Recombinant Human Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Erythropoietin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Growth Hormones Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Purified Proteins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inflammatory and Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bio-pharma Consumption Forecast by Country (2022-2028)
-
Table North America Bio-pharma Consumption Forecast by Country (2022-2028)
-
Figure United States Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Bio-pharma Consumption Forecast by Country (2022-2028)
-
Figure Germany Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Bio-pharma Consumption Forecast by Country (2022-2028)
-
Figure China Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Bio-pharma Consumption Forecast by Country (2022-2028)
-
Figure Brazil Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Bio-pharma Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Bio-pharma Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Bio-pharma Consumption Forecast by Country (2022-2028)
-
Figure Australia Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
